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The lpr locus was defined by an autosomai recessive mutation initially observed 
in  strain  MRL  (1).  Whereas  nonmutant  mice of this  strain  develop late-onset 
autoimmune disease characterized by chronic glomerulonephritis,  MRL-lpr/lpr 
mice experience  severe ear!y-onset subacute glomerulonephritis,  arteritis,  and 
arthritis associated with massive lymphadenopathy and splenomegaly (1-3). The 
lymph  nodes  and  spleens  of lpr  homozygotes are  expanded  by an  abnormal 
population of cells that coexpress cell surface determinants  usually restricted to 
T  cells (Thy-1,  Ly-1) or  B  cells [Ly-5(B220)] (4-9),  and are  deficient  in  their 
ability to produce interleukin 2 (IL-2)  1 (9-12). These aberrant cells were clearly 
shown not to be B cells, in that  they had no rearrangements  of Ig heavy chain 
genes  (6).  MRL-lpr/+  resemble  MRL-+/+  mice  in  terms  of disease patterns, 
longevity, and  phenotypic and  functional  characteristics  of their  lymphocytes, 
indicating that the mutation is fully recessive in this strain. 
To  determine  if this  mutation  would  produce  similar  abnormalities  when 
present  on  other  genetic  backgrounds,  lpr  was  backcrossed  onto  strains 
NZB/BINJ, SJL/J, C3H/HeJ, AKR/J, C57BL/6J, and BALB/cJ. Ongoing phen- 
otypic, functional, and histopathologic studies of mice (from these strains) homo- 
zygous for lpr have shown that, although aberrant T  cells were detected in the 
lymphoid  tissues  of mice  from  all  strains  (6,  9,  and  H.  C.  Morse  III,  W.  F. 
Davidson,  and  J.  B.  Roths,  unpublished  observations),  lpr/lpr  mice  differed 
considerably among strains in the degree of lymphadenopathy they exhibited, as 
well as in their longevity and rates of development, and severity of the autoim- 
mune  disease  they  incurred  (5,  9-13,  and  J.  B.  Roths  and  E.  D.  Murphy, 
unpublished observations). 
During the course of these studies, it was noted that the survival of SJL-lpr/+ 
mice  was  shortened  in  comparison  to  SJL-+/+  mice,  suggesting  that,  in  this 
strain,  lpr had an  effect in the heterozygous state.  To evaluate this possibility, 
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SJL-lpr/lpr, -lpr/+, and -+/+ mice were compared for longevity, histopathology, 
expression of murine leukemia viruses (MuLV), and phenotypic characteristics 
of lymphocytes. 
Materials and Methods 
Mice.  All mice were bred by J. B. Roths and E. D. Murphy or were purchased from 
the Animal Resource colonies of The Jackson Laboratory, Bar Harbor, ME, except for 
NFS/N, which was obtained from the colonies of the National Institutes of Health. Mice 
of different strains bearing the lpr mutation had been through at least seven cycles of 
cross-intercross matings at the time of study. 
Histopathology.  Moribund  mice were  sacrificed and  tissues were  fixed  in  Fekete's 
formal-acetic-ethanol solution. Sections (8 t~m) were stained with hematoxylin and eosin 
for microscopic examination. Sections of  kidney were also stained with PAS/Schiffreagent. 
Virus Studies.  Infectious center assays  for ecotropic, xenotropic, and MCF MuLV were 
performed with mitomycin-C-treated lymphoid cells, as previously described  in detail 
(14, 15). Infectious  ecotropic  MuLV in  2%  (wt/vol) extracts  of tail biopsies (16) was 
quantitated by UV-XC tests of SC-1 cells inoculated with 0.2 ml of extract. 
Flow Microfluorometry (FMF).  Single-cell suspensions from thymus, spleen, and lymph 
nodes were prepared and stained  for FMF analyses using established procedures  (14). 
The antibodies  used in this study and their specificities for normal hematopoietic  cells 
have previously been described in detail (6, 9,  12,  17-21).  Antibodies to Thy-1, surface 
Ig (sIg), Ly-5(B220), ThB,  Ly-5, XenCSA  (14), and  "8C5" were  fluorescein  labeled. 
Antibodies to "H-11", Ly-24 and Mac-1 were sandwiched with affinity-purified, fluores- 
cein-labeled rabbit anti-rat Ig. Antibodies to Ly-1, Ly-17, Ia and Lyb-2  were sandwiched 
with affinity-purified goat anti-mouse IgG2. Fluorescence profiles were generated on a 
FACS II (B-D FACS Systems, Sunnyvale, CA) from 3 ×  104  viable nucleated  cells (as 
determined by combined gating with propidium iodide to exclude dead cells, and narrow 
forward-angle light scatter to exclude red cells), using logarithmic amplification of signals 
from the photomultiplier  tubes. 
DNA Analyses.  High molecular weight DNA was prepared, cleaved with restriction 
endonucleases,  and  separated  by  electrophoresis  on  0.6% agarose  gels as  previously 
described (22). After transfer to nitrocellulose membranes,  the blots were probed with 
32P-labeled pBR322  containing an ecotropic  envelope-specific DNA fragment, pEc-B4 
(23) using established techniques (22). 
Results 
Lymphoproliferation in Mice Homozygous for lpr.  In earlier studies, we found 
that lpr induced lymphadenopathy in different inbred strains homozygous for 
the  mutation (13),  and  that the nodes of these mice were expanded with an 
abnormal population of Thy-  1  +,Ly-  1  ÷,Ly-2- or Thy- 1-,Ly-  1  +,Ly-2- T  cells bear- 
ing the B cell surface marker, Ly-5(B220) (6-9).  The effect of lpr on lymphad- 
enopathy in SJL mice homozygous for the mutation was compared at 10 and 26 
wk with that in C3H-, MRL-, AKR-, and C56BL/6-1pr/lpr mice (Fig.  1). At 10 
wk, nodes of SJL-lpr/lpr mice were significantly larger than those of other strains 
homozygous for lpr.  At 26  wk,  however, SJL-lpr/lpr nodes were only slightly 
larger than those of MRL-lpr/lpr  mice, and were smaller than those of C3H- 
lpr/lpr mice. 
Lymph node and  spleen  cells  from 4.5-6-mo-old  SJL-+/+ and SJL-lpr/lpr 
mice were tested by FMF for expression of a series of cell surface antigens (Table 
I). As for other strains homozygous for lpr, the predominant phenotype of LN 
cells from SJL-lpr/lpr mice was Thy-1 +, H-11 +, Ly-5(B220)  +, Ly-5  +, Ly-2-, sIg-, 700 
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FIGURE  1.  Lymphadenopathy in SJL/J, C3H/HeJ, MRL/MpJ, AKR/J, and C57BL/6J mice 
homozygous for lpr at 10 wk (hatched) and 26 wk of age (open). Bars indicate the mean weight 
of pooled axillary, renal, lumbar, and mesenteric lymph nodes of five to Six mice at each time 
point.  Numbers at the top of the open  bars indicate the relative increase in the weight of 
lpr]lpr lymph nodes as compared with +]+ nodes for each strain at age 26 wk.  The mean 
weight of +/+ lymph nodes from all strains is indicated by the open bar at the right side of 
the figure. 
ThB-,  Ia-  (6-9).  The reduced  frequency of Ly-1 + cells in  LN  of these  mice 
contrasts with the increased frequency of these cells in the other lpr strains tested 
(6). The frequency of Thy-1 + and Ly-5(B220) + cells was also increased in spleen 
but to a  lesser extent than LN, again paralleling studies of other strains homo- 
zygous for lpr (6-9). 
The frequency of cells bearing markers not previously examined in lpr mice 
was also determined. These include Lyb-2 (24), the B cell-specific antigen; Ly- 
17  (18),  the granulocyte-specific marker;  "8C5"  (R.  L.  Coffman, H.  C.  Morse 
III,  unpublished observations),  the  myelomonocytic determinant;  Mac-1  (19), 
and  an  antigen  expressed  by  the  great  majority  of hematopoietic cells of all 
lineages, Ly-24 (20, 21). The frequencies of Lyb-2  + and Ly-17 + cells in both lpr/ 
lpr and normal tissues corresponded closely to the frequencies of B cells defined 
by  expression  of sIg,  ThB or  Ia  (Table  I),  emphasizing that  the  only  B  cell 
determinant greatly altered in expression on lpr cells is Ly-5(B220). 
The frequencies of spleen but not LN  cells expressing antigens confined to 
the myelomonocytic lineage (8C5,  Mac-l)  were increased slightly in lpr mice, 
corresponding, in part, with reports of increases in macrophages in other strains 
homozygous for lpr (25, 26). By comparison, the frequency of cells bearing Ly- 
24, the major surface glycoprotein of phagocytic cells (20,  21), and the density 
of Ly-24 antigens per cell was greatly increased in lpr as compared with normal 
SJL mice (Table  I  and Fig.  2).  In regard to the altered  representation of Ly- 
5(B220)  and  Ly-24  antigens on SJL-lpr/lpr  cells,  it  should be  noted  that lpr 
clearly  is  not  linked  to  the  loci  on  chromosome  1  or  chromosome  2  that, T
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FIGURE 2.  FMF analyses of spleen and lymph node cells from SJL-lpr/lpr (solid lines) and 
SJL-+/+ mice (dashed lines)  reacted  with  anti-Ly-24,  washed,  and then treated with  fluorescein 
isothiocyanate-labeled  rabbit anti-rat Ig. 
FIGURE  3. 
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Mortality curves for SJL-+/+, SJL-tpr/+,  and SJL-Ipr/lpr  mice. 
respectively, control expression of these cell surface markers (J. B. Roths, E. D. 
Murphy, unpublished results). 
Lifespans and Disease Patterns of SJL-+/+,  -Ipr/+,  and -lpr/Ipr  Mice.  We com- 
pared the longevity of mutant homozygous or heterozygous mice, or homozygous 
wild types (Fig. 3).  The lifespan of lpr homozygotes was markedly shortened in 
comparison with that of +/+ mice (mean survival of lpr/lpr was  155  _+  18 d vs. 
408 +  28 d for homozygous wild types; P <  0.001). By comparison, the survival 
curve for lpr/+  mice was intermediate to that of the other populations (mean 
survival was 268 +  16 d, P <  0.001  compared with either lpr/lpr or +/+). 
Gross and microscopic examinations of tissues from 5-6-mo-old SJL-lpr/lpr 
mice revealed marked differences to the pathology described for MRL-lpr/lpr 
mice. Whereas MRL-lpr/lpr mice die with severe renal disease (Fig. 4 D) (1-3), 
vasculitis (Fig. 4 F), including myocardial infarctions (27) and arthritis (28),  SJL- 
lpr/lpr mice exhibited minimal renal lesions (Fig. 4 C), rare focal vasculitic lesions 
(Fig. 4 E), and had none of the clinical signs of arthritis shown by MRL-lpr/lpr 
mice (J. B. Roths, personal observations). However, perivascular, peribronchio- 
lar, interstitial and intraalveolar infiltrates of lymphocytes  and inflammatory cells FIGURE 4.  Histopathology of 5-mo-old SJL[J-lpr/ID  r (A, C, E) and MRL/Mp-lpr/lpr (B, D, 
F)  mice.  (A and B)  Lung,  hematoxylin and  eosin.  ×  46.  (A) Extensive perivascular and 
peribronchial infiltration of lymphoid cells  and  chronic  interstitial inflammatory disease 
especially prominent at the periphery. Dense accumulations of lymphoid cells fill alveolar 
spaces.  (B) Limited perivascular and peribronchial infiltration without interstitial disease.  (C 
and D) Kidney, periodic acid/Schiff, ×  114.  (C) Essentially  normal glomerular and tubular 
morphology. (D) Extensive glomerular disease with sclerosis,  crescent formation, adhesions 
and periglomerular interstitial lymphoid infiltration. (E and F) Submandibular gland, hema- 
toxylin and  eosin,  ×  285.  (E)  Normal  morphology. (F)  Extensive perivascular lymphoid 
infiltration, chronic arteritis, and periarteritis characterized by thickened eosinophilic intima, 
narrowed lumen, and fibrous tissue in the adventitia. 
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were striking histologic features of lung sections from SJL-lpr/lpr mice (Fig. 4 
A),  whereas  pulmonary  lesions  in  MRL-lpr/lpr  mice  were  limited  to  some 
perivascular and peribronchiolar cuffing without alveolar infiltrates (Fig.  4 B). 
Sections from other tissues of SJL-lpr/lpr mice showed venous congestion and 
capillary stasis.  In view of the marked reduction in the volume of the thoracic 
cavity occasioned by lymph node hypertrophy, the lung lesions of SJL-lpr/lpr 
mice probably result  in  death  due to  pulmonary insufficiency combined with 
right-sided heart failure. 
Comparable histopathologic studies of nine moribund SJL-/pr/+ mice showed 
that  all  the  animals  died  with  lymphomas, of apparent  B  cell  origin,  which 
resembled the characteristic neoplasms of SJL-+/+ mice (29).  Using a recently 
defined system that  allows  comparisons of the  histopathology of murine and 
human lymphomas (30,  31),  the lesions of SJL-lpr/+  mice included follicular 
center cell  lymphomas,  immunoblastic  lymphomas,  and  a  plasmacytoid  lym- 
phoma. 
In Vivo and In Vitro Passage of lpr/+ Lymphomas.  In earlier studies, (32-34) it 
was found that SJL-+/+ lymphomas may be difficult to establish as continuous 
in vivo or in vitro lines, raising the possibility that the SJL-lpr/+ and -+/+ lesions 
may not be truly malignant, in spite of their histologic appearances. To evaluate 
this question, young adult SJL-+/+  mice were inoculated subcutaneously with 
fragments of lymph nodes from +/+ and lpr/+ mice carrying lymphomas. The 
transplantation studies demonstrated that both +/+ and lpr/+ lymphomas could 
be passaged in +/+ recipients. The frequency with which the lymphomas were 
successfully transplanted  was  higher  for  lpr/+  (78%,  n  =  9)  than  for  +/+ 
lymphomas (59%, n =  27). 
Studies of MuLV.  Expression of infectious endogenous or exogenous MuLV- 
related  genomes has  been  shown  to  influence the  development of B  lineage 
lymphomas (31,  35).  To determine if the effects of lpr on B cell neoplasms in 
SJL mice could be related to alterations in production of MuLV, tissues from 
prelymphomatous +/+ and lpr/+ mice, as well as lpr/lpr mice were tested for 
expression  of infectious ecotropic,  xenotropic, and  mink  cell  focus-inducing 
(MCF) MuLV.  Viruses belonging to the latter two classes of MuLV were not 
produced by thymocytes, lymph node or spleen cells from any of the animals 
tested (data not shown), but infectious ecotropic MuLV was produced, to a highly 
variable extent, by lymphocytes from all three types of mice (Table II). The data 
in this table can be summarized as follows: First, a low proportion (<102 out of 
107) of cells  from thymus, spleen,  or  lymph nodes from  +/+  mice produced 
infectious ecotropic MuLV. Second, >5 ×  10 2 OUt of 10 7 cells from all lymphoid 
tissues of lpr/lpr mice 3  mo of age or older produced infectious virus of this 
class.  Finally, the virus phenotype of tissues from Ipr/+ mice appeared to differ 
from  that  of +/+  or  lpr/lpr  mice.  The  frequency of virus-positive  mice  at 
different ages, and  the  frequency of virus-producing cells from virus-positive 
animals tended to be higher in lpr/+ than in +/+ mice, but lower than in lpr/ 
lpr mice. It should be noted that this trend is especially apparent for Ipr/+ mice 
no more than  4  mo old.  In the older age groups (>4 mo), mice with prelym- 
phomatous lesions or overt lymphomas were excluded to avoid the possibility 
that expression of MuLV might be altered by neoplastic changes. These results MORSE  ET  AL.  609 
TABLE II 
Expression  of lnfectious Ecotropic MuL V in Lymphoid Tissues of Prelymphoraatous SJL Mice 
XC Plaques/10 7 Cells (Iogt0) 
Age  Thymus  Spleen  Node 
+/+  tp,/+  tp,ltp~  +/+  tp,/+  tp,/lp,  +/+  lp,/+  lp,/lpr 
mo 
2.,5  -*,  --  -,  0.0  <1.0,  -  0.8,  1.5  1.2, 0.8  <1.0,  2.8  -,  -  --, -  <I.0,  2.8 
3.0  -,-  1.5, 2.2  3.0, 2.8,3.1  2.6,  2.6, 
1.9 
3..5  ,  ,  1.4, -,  -  1.2,  1.3,  1.0  3.2,  1.2, 2.3  0.8, -,  -  1.5, 0.5 
4~0  ,  ,  3.6, 0.$  4.0, 2.9, 2.7  0.8, 0.6,  1.8  2.5, 0.8  4.0, 3.9, 3.4  -,  -  3.3, 0.5  4.0, 3.5, 
3.9 
.5.0  -  1.6 
5..5  ,  ,  0.7,  1.9, -  -,  1.7, 0.6  -,I.2,-  -,  1.1, - 
9 
2.4  0.3, 2.0  -,  2.0  -,  1.7  -  1.6 
6.0  -,  -  2.8, 5.1  1..5,  1.0  4.0,  5.5 
6.5  -,  1.5, -  4.7  1.4, 2.3,  1.7  >5.0  1.6, 2,$,  1.0  >5.0 
*  -  Denotes no plaques/10 T cells. 
TABLE  III 
Expression  of Infectious  MuLV in Lymphoid Tissues of Strains Homozygous For lpr 
Ecotropic virus (XC plaques/10  T  cells  [Iogl0]) 
Strain  Thymus  Spleen  Node 
+1+  lpr/lpr  +1+  lpr/lpr  +1+  lpr/lpr 
C57BL/6J  -*  ,  ,  -  -, <0.3 
C3H/HeJ  1.3  1.4 
AKR/J  5.1, 4.3  4.3, 5.0  5.1, 5.0  5.1, 5.1  5.2, 4.9  4.9, 4.8 
Xenotropic virus (S+L  - foci/10  ~  cells [log10]) 
NZB/BINJ  2.4, 2.5  3.0, 3.3  3.9, 3.9  3.7, 3.8  2.6, 3.0  3.3, 3.3 
*  -  Denotes  no plaques/10  ~  cells. 
demonstrate that expression of infectious ecotropic MuLV is markedly increased 
in  lymphoid  tissues  of  SJL-lpr/lpr  vs.  -+/+  mice,  and  suggest  that  MuLV 
expression may be enhanced in Ipr/+ mice, but to a lesser and variable extent. 
We studied the possibility that  heightened  expression of infectious ecotropic 
MuLV  in  SJL-lpr/lpr  mice  might  occur  in  nonlymphoid  as  well  as  lymphoid 
tissues by testing cell-free extracts from tail biopsies of eight lpr/lpr,  four lpr/+, 
and eight +/+ mice 2-4.5 mo old. Extracts from one lpr/lpr and two +/+ mice 
produced  low  numbers  (2-26)  of XC  cell  line  plaques  under  conditions  that 
would yield > 10  s plaques in comparable tests of AKR mouse tissue. These data 
suggest that  expression of infectious ecotropic MuLV is amplified in lymphoid 
but not in nonlymphoid tissues of SJL-lpr/lpr  mice. 
Two major questions are raised by these observations. First, is the alteration 
in MuLV expression detected in SJL-lpr/lpr  mice restricted to this strain,  or is 
virus expression also changed in other lpr congenics? This question was examined 
by testing lymphoid tissues from 3-5-mo-old C57BL/6J, C3H/HeJ, AKR/J, and 
NZB/BINJ lpr  homozygotes and  +/+  mice  for expression of infectious MuLV 
(Table III).  The proportions of thymocytes, spleen cells, and lymph node cells 610  ABNORMALITIES  INDUCED  BY  THE  MUTANT  GENE,  lpr 
producing ecotropic MuLV were not significantly altered by the lpr mutation in 
the  ecotropic  MuLV-positive  strains  C57BL/6,  AKR,  or  C3H,  and  neither 
xenotropic nor  MCF MuLV were detected in any of the cultures of cells from 
these mice.  Tests for infectious xenotropic MuLV in ecotropic MuLV-negative 
NZB mice showed no  significant  differences between +/+  and  lpr/lpr  for the 
proportions of virus-producing cells from spleens or lymph nodes. The difference 
between normal and lpr mice for expression of infectious xenotropic MuLV by 
thymocytes (Table III) may reflect contamination of lpr/lpr thymus preparations 
with parathymic lymph nodes or abnormal cells infiltrating the thymuses of these 
mice.  Taken  together,  the analyses of MuLV in  different  strains  indicate  that 
the effect of lpr on virus expression is limited to ecotropic loci in SJL mice. 
Second,  since  the  lpr  gene  introduced  into  SJL  came  from  MRL,  a  strain 
derived from crosses between AKR,  C57BL/6,  C3H/Di,  and  LG (1),  does the 
altered  expression  of ecotropic  MuLV  in  SJL-lpr/lpr  mice  reflect inadvertent 
introduction  of an  ecotropic locus from  one of'these strains  to SJL in  linkage 
with or unlinked  to lpr, or was Ipr introduced into linkage with one of the SJL 
ecotropic loci? To evaluate these possibilities, Southern blots of restricted cellular 
DNA from SJL-+/+ and lpr/lpr mice were hybridized with a probe specific for 
the  env gene  of ecotropic  MuLV  (data  not  shown).  The  results  demonstrated 
that mutant mice had two ecotropic MuLV-related sequences identical in size to 
those in SJL-+/+ DNA, indicating that lpr alters the expression of one or both 
of the endogenous MuLV sequences found in normal SJL mice (36). 
To determine if altered MuLV expression might reflect linkage between one 
of the SJL ecotropic MuLV loci and lpr, virus-negative NFS/N female mice were 
bred to SJL-lpr/lpr  male  mice, and  F1  males were then backcrossed to NFS/N 
females. Backcross females were tested for lpr by matings with B6-1pr/lpr mice, 
and for SJL ecotropic MuLV loci by Southern blot hybridization of their splenic 
DNA restricted  with  Xba  I  with an  ecotropic env-specific probe, pEc-B4.  The 
results of these analyses (Table IV) showed that one of two mice inheriting  the 
6.3 kb pEc-B4-reactive Xba I fragment, two out of five mice inheriting the 11.5 
TABLE  IV 
Relations Between  Ecotropic  MuL V Loci and lpr in SJL-lpr/lpr Mice 
pEc-B4-Reactive Xba I 
Mouse*  Fragment  lpr  lpr/lpr in 
progeny test 
6.3 kb  11.5 kb 
6106  -  -  -  0/7 
6107  +  -  +  4/8 
6108  -  +  -  0/9 
6109  -  +  +  4/10 
6110  -  +  -  0/11 
6111  +  -  -  0/7 
6112  -  +  -  0/8 
6113  -  -  -  0/9 
6114  -  +  +  2/6 
*  Backcross (NFS ×  SJL-lpr/lpr)  × NFS mice (6106-6114)  outcrossed to 
C57BL/6-1pr/lpr to test for presence of lpr. DNA prepared from spleens 
was restricted with Xba I, and tested for pEc-B4-reactive sequences. MORSE  ET  AL.  611 
kb fragment, and none of two mice that inherited neither fragment were lpr/+. 
The results indicated that lpr was not linked to either of the SJL ecotropic MuLV 
loci. 
Discussion 
The data presented in this report demonstrate a number of important points 
regarding abnormalities related to the lpr mutation. From information presented 
here and elsewhere, it is clear that the lpr mutation consistently induces certain 
abnormalities,  regardless  of strain  background,  but  that  other  abnormalities 
associated with the mutation are highly strain-dependent. Thus, for all  strains 
tested, lpr induces lymphadenopathy and splenomegaly, although there is strain- 
to-strain variation in the extent of proliferation (Fig.  1) (13). Lymph nodes and 
spleens of lpr mice from all strains are expanded with cells that coexpress cell 
surface antigens  usually restricted  to  T  cells  (Thy-1) or  B  cells  [Ly-5(B220)] 
(Table  I)  (6-9).  These  cells  are  definitely not  of B  cell  origin,  as  (a)  their 
expansion is limited in neonatally thymectomized mice (37,  38),  and (b) most 
express Ly-1 in addition to Thy-1 (Table I) (4-9). In addition, lpr homozygotes 
of all  strains produce antinuclear antibodies (13  and J.  B.  Roths,  unpublished 
data). 
In contrast, the effects of the lpr mutation on the development of autoimmune 
disease and expression of MuLV are markedly strain-dependent. MRL-lpr/lpr 
mice develop  accelerated immune-complex glomerulonephritis,  arthritis,  and 
vasculitis (1-3, 27, 28), whereas C3H-lpr/lpr and SJL-lpr/lpr mice develop little 
or no  renal, joint,  or vascular disease (Fig.  4) (12).  Instead,  SJL-lpr/lpr  mice 
developed extensive lymphocytic and  inflammatory cell pulmonary infiltrates, 
and  appeared  to  die  with  combined  pulmonary insufficiency and  right-sided 
heart failure. 
Among strains  homozygous for lpr and  tested  for expression  of infectious 
MuLV, the mutation appears to affect only ecotropic MuLV in SJL mice (Tables 
II and III). The mechanisms responsible for enhanced MuLV expression in this 
strain are unknown, but linkage studies clearly demonstrated that this phenom- 
enon did not reflect linkage of the lpr gene to one of the two endogenous SJL 
ecotropic MuLV loci (Table IV).  Furthermore, no evidence of additional eco- 
tropic MuLV loci was found. 
Our results also indicated that the lpr gene may be expressed to some extent 
in the heterozygous state on the SJL background, but not on other backgrounds. 
This view is based most firmly on the observation of a significant difference in 
survival between SJL-+/+ and -lpr/+ mice (Fig. 3), and less certainly on enhanced 
expression of ecotropic MuLV in SJL-lpr/+ mice <4 mo old (Table II). Similar 
effects have not been observed with B6, AKR, or MRL lpr heterozygotes. It is 
noteworthy that the apparent effects of this gene in the heterozygous state only 
partially resemble its effects in the homozygous state. Thus, although SJL-lpr/+ 
mice exhibited a  shortened life span and enhanced expression of MuLV, they 
died  with  lymphomas rather  than  pulmonary disease,  they did  not  produce 
antinuclear antibodies (J. B.  Roths, unpublished observation), and their spleens 
and nodes did not contain cells phenotypically characteristic of lpr homozygotes. 
The origins and characteristics of the cells responsible for lymphomas of SJL- 612  ABNORMALITIES  INDUCED BY  THE  MUTANT GENE, lpr 
+/+  mice  have  been  studied  since  the  initial  description  of these  lesions  as 
reticulum cell sarcomas in 1963 (29). No consensus of  opinion has been developed 
regarding this disease, as some cell lines obtained from old SJL mice were shown 
to  have characteristics of cells in  the  B  lymphocyte lineage (32-34),  whereas 
others had characteristics of macrophages or histiocytes (39).  The observation 
that these neoplasms do not develop in SJL mice rendered deficient of B cells by 
treatment from birth with anti-IgM (40), is one of the strongest lines of evidence 
for the B cell nature of these lymphomas. In the current study, we demonstrated 
that SJL-lpr/+ mice died with lymphomas that resembled neoplasms of SJL-+]+ 
mice. Using recently developed criteria for classification of murine lymphomas 
(30,  31),  the  neoplasms  of both  +/+  (data  not  shown) and  lpr/+  mice  had 
characteristics of follicular center-cell and immunoblastic lymphomas. The ma- 
lignant nature of some of the lpr/+ lymphomas was documented by their growth 
after transplantation.  Continuous in vitro cell lines were established from some 
of the  lpr/+  neoplasms,  but  their  relationship  to  the  primary  neoplasms  is 
uncertain. 
The relationship between MuLV and the development of B-lineage lymphomas 
has  recently  been  clarified  to  some  extent.  Two  findings  demonstrate  that 
ecotropic MuLV are not required for the development of spontaneous or induced 
B-lineage neoplasms, and thus suggest, indirectly, that MCF MuLV are also not 
required.  First,  NFS  mice,  which  lack  the  genetic  information  for  ecotropic 
viruses,  develop a  low  frequency of spontaneous  B  cell  lymphomas (31,  35). 
Second, BALB]c mice congenic for the Rmcf" locus of DBA]2 (41), and lacking 
ecotropic  MuLV,  develop plasmacytomas (after treatment with  pristane)  at  a 
frequency equivalent to that of normal BALB/c mice (42). However, NFS mice 
congenic for ecotropic MuLV induction loci from AKR or C58  have a  much 
higher frequency of B-lineage lymphomas than normal NFS mice, indicting that 
ecotropic  MuLV  can  amplify  the  tendency of this  strain  to  develop  B  cell 
neoplasms (31, 35). Enhanced expression of ecotropic MuLV early in the life of 
SJL-lpr/+ mice (Table II) may also act to accelerate the development of neo- 
plasms. The mechanism of such amplification is unknown, but ecotropic virus- 
induced generation  of some  type  of recombinant  MuLV  could  be  involved. 
Second, although MCF MuLV have been recovered from nonthymic lymphomas 
of NFS (15) and SJL-lpr/+ mice (data not shown), these viruses have not been 
shown to accelerate the development of similar neoplasms in mice inoculated as 
newborns. 
Taken together with data from earlier studies, these results indicate the marked 
complexities involved in studies of autoimmune disease, even when "single gene 
models" are  studied.  The  lpr  mutation  was  initially  considered as  a  disease- 
inducing alteration of the genome (1, 2), but has subsequently been viewed as a 
defect accelerating the autoimmune disease of MRL/Mp mice (3,  11, 27). Other 
strains homozygous for this mutation develop little or no evidence of autoim- 
munity, aside from autoantibodies (9,  13, 43), and die with undetermined causes 
(9) or, in the case of SJL/J, pulmonary disease (as described herein). 
These strain differences may reflect the fact that this single mutation alters 
the expression of many cellular genes, including those governing expression of 
cell surface antigens (5-9), protooncogenes (44), and endogenous MuLV (Table MORSE  ET  AL.  613 
II).  In  some  cases,  expression  of these  genes  is  enhanced;  in  other  instances 
expression is depressed. This variation appears to be, in part, strain-dependent. 
Although  elucidation  of these  strain-related  effects is  clearly  important,  it  is 
unlikely that  a  fundamental  understanding  of the abnormalities  caused by the 
lpr mutation will be obtained until the primary defect, probably enzymatic, has 
been  described.  In  this  regard,  it  has  been  suggested  that  the  abnormalities 
induced by lpr and the nonallelic mutation, gld (45) may reflect defects common 
to a metabolic pathway of importance to T  cell differentiation and function (46). 
Summary 
SJL/J mice heterozygous or homozygous for the lpr mutation were compared 
with SJL/J-+/+  mice for longevity, histopathology, antigenic  characteristics  of 
lymphocytes and expression of murine leukemia viruses (MuLV). In comparison 
to +/+  mice,  lpr homozygotes had  a  markedly shortened  life span,  died with 
infiltrative pulmonary disease, but little or no renal disease, and expressed high 
levels of infectious ecotropic MuLV in lymphoid tissues. SJL-lpr/+  mice had a 
life span intermediate between SJL-+/+ and dpr/lpr mice, died with lymphomas 
that  histologically  resembled  the  neoplasms  of +/+  mice,  and  sometimes  ex- 
pressed  high  levels  of ecotropic  MuLV.  The  lymphomas  of lpr/+  could  be 
transplanted  to  +/+  recipients  in  78%  of cases,  and  continuous  in  vitro  lines 
were  established  from  some  of them.  Similar  effects on  virus  expression  or 
lymphoma  development  were  not  observed  in  other  strains  homozygous  or 
heterozygous  for  the  lpr  mutation.  These  results  indicate  that  the  diseases 
expressed by mice homozygous for the lpr mutation are highly strain-dependent, 
and that this gene can have an effect in the heterozygous state in SJL mice. 
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